🇺🇸 FDA
Patent

US 7005262

Methods for detecting nucleic acids encoding human telomerase reverse transcriptase

expired A61KA61K38/00A61K39/00

Quick answer

US patent 7005262 (Methods for detecting nucleic acids encoding human telomerase reverse transcriptase) held by The Regents of the University of Colorado expires Mon Feb 23 2026 00:00:00 GMT+0000 (Coordinated Universal Time). Status: expired.

Key facts

Applicant
The Regents of the University of Colorado
Grant date
Tue Feb 28 2006 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Feb 23 2026 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
40
CPC classes
A61K, A61K38/00, A61K39/00, A61K48/00